Show simple item record

dc.contributor.authorCardwell, Karen
dc.contributor.authorClyne, B
dc.contributor.authorMoriarty, F
dc.contributor.authorWallace, E
dc.contributor.authorFahey, T
dc.contributor.authorBoland, F
dc.contributor.authorMcCullagh, L
dc.contributor.authorClarke, S
dc.contributor.authorFinnigan, K
dc.contributor.authorDaly, M
dc.contributor.authorBarry, M
dc.contributor.authorSmith, S M
dc.date.accessioned2019-01-25T10:00:37Z
dc.date.available2019-01-25T10:00:37Z
dc.date.issued2018-01-01
dc.identifier.issn2055-5784
dc.identifier.pmid30002869
dc.identifier.doi10.1186/s40814-018-0311-7
dc.identifier.urihttp://hdl.handle.net/10147/624033
dc.description.abstractPrescribing for patients taking multiple medicines (i.e. polypharmacy) is challenging for general practitioners (GPs). Limited evidence suggests that the integration of pharmacists into the general practice team could improve the management of these patients. The aim of this study is to develop and test an intervention involving pharmacists, working within GP practices, to optimise prescribing in Ireland, which has a mixed public and private primary healthcare system. This non-randomised pilot study will use a mixed-methods approach. Four general practices will be purposively sampled and recruited. A pharmacist will join the practice team for 6 months. They will participate in the management of repeat prescribing and undertake medication reviews (which will address high-risk prescribing and potentially inappropriate prescribing, deprescribing and cost-effective and generic prescribing) with adult patients. Pharmacists will also provide prescribing advice regarding the use of preferred drugs, undertake clinical audits, join practice team meetings and facilitate practice-based education. Throughout the 6-month intervention period, anonymised practice-level medication (e.g. medication changes) and cost data will be collected. A nested Patient Reported Outcome Measure (PROM) study will be undertaken during months 4 and 5 of the 6-month intervention period to explore the impact of the intervention in older adults (aged ≥ 65 years). For this, a sub-set of 50 patients aged ≥ 65 years with significant polypharmacy (≥ 10 repeat medicines) will be recruited from each practice and invited to a medication review with the pharmacist. PROMs and healthcare utilisation data will be collected using patient questionnaires, and a 6-week follow-up review conducted. Acceptability of the intervention will be explored using pre- and post-intervention semi-structured interviews with key stakeholders. Quantitative and qualitative data analysis will be undertaken and an economic evaluation conducted. This non-randomised pilot study will provide evidence regarding the feasibility and potential effectiveness of general practice-based pharmacists in Ireland and provide data on whether a randomised controlled trial of this intervention is indicated. It will also provide a deeper understanding as to how a pharmacist working as part of the general practice team will affect organisational processes and professional relationships in a mixed public and private primary healthcare system.
dc.language.isoenen_US
dc.publisherPilot and Feasibility Studiesen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectPHARMACYen_US
dc.subjectGENERAL PRACTICEen_US
dc.subjectPrimary careen_US
dc.subjectRANDOMISED CONTROLLED TRIALen_US
dc.titleSupporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care.en_US
dc.typeArticleen_US
dc.identifier.journalPilot and Feasibility Studiesen_US
dc.source.journaltitlePilot and feasibility studies
refterms.dateFOA2019-01-25T10:00:37Z


Files in this item

Thumbnail
Name:
supporting.pdf
Size:
754.2Kb
Format:
PDF
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States